Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN

The proliferation marker Ki‐67 is widely used within the field of diagnostic histopathology as a prognostic marker for solid cancers. However, Ki‐67 is hardly used for prognostic and diagnostic purposes in flow cytometric analyses of hematologic neoplasms. In the present study, we investigated to wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Mestrum, Stefan G. C., de Wit, Norbert C. J., Drent, Roosmarie J. M., Hopman, Anton H. N., Ramaekers, Frans C. S., Leers, Math P. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247351/
https://www.ncbi.nlm.nih.gov/pubmed/32857909
http://dx.doi.org/10.1002/cyto.b.21946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247351/
https://www.ncbi.nlm.nih.gov/pubmed/32857909
http://dx.doi.org/10.1002/cyto.b.21946

Ejemplares similares